ENDOLOGIX INC's ticker is and the CUSIP is 29266SAB2. A total of 14 filers reported holding ENDOLOGIX INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,291,000 | -13.4% | 1,500,000 | 0.0% | 0.12% | -14.7% |
| Q1 2017 | $1,490,000 | -15.2% | 1,500,000 | -25.0% | 0.14% | -32.5% |
| Q4 2016 | $1,758,000 | +512.5% | 2,000,000 | +566.7% | 0.21% | +430.0% |
| Q1 2016 | $287,000 | -12.2% | 300,000 | 0.0% | 0.04% | -21.6% |
| Q4 2015 | $327,000 | – | 300,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERBACK ASSET MANAGEMENT LLC | 4,000,000 | $3,760,000 | 0.56% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |